Effects of rosiglitazone +/- nitroglycerin vs nitroglycerin on endothelial function in volunteers

Trial Profile

Effects of rosiglitazone +/- nitroglycerin vs nitroglycerin on endothelial function in volunteers

Completed
Phase of Trial: Phase IV

Latest Information Update: 28 Sep 2012

At a glance

  • Drugs Rosiglitazone (Primary) ; Nitroglycerin
  • Indications Alzheimer's disease; Erectile dysfunction; Heart failure; Ischaemic heart disorders; Psoriasis; Type 2 diabetes mellitus
  • Focus Pharmacodynamics
  • Most Recent Events

    • 28 Sep 2012 New trial record
    • 01 Sep 2012 Results published in the Journal of Cardiovascular Pharmacology and Therapeutics.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top